{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:26:56Z","timestamp":1793287616978,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bpobgyn.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T02:48:55Z","timestamp":1518662935000},"page":"68-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Medical treatment of endometriosis-related pain"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-0996","authenticated-orcid":false,"given":"Paolo","family":"Vercellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Buggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pina","family":"Frattaruolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhouha","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Somigliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2018.01.015_bib1","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1093\/humrep\/dep231","article-title":"Medical treatment for rectovaginal endometriosis: what is the evidence?","volume":"24","author":"Vercellini","year":"2009","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2018.01.015_bib2","article-title":"Endometriosis: an overview of cochrane reviews","author":"Brown","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.fertnstert.2016.10.022","article-title":"Estrogen-progestins and progestins for the management of endometriosis","volume":"106","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2017.05.004","article-title":"Reevaluating response and failure of medical treatment of endometriosis: a systematic review","volume":"108","author":"Becker","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/13543784.2016.1126579","article-title":"An overview of early drug development for endometriosis","volume":"25","author":"Leone Roberti Maggiore","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.fertnstert.2016.12.025","article-title":"New developments in the medical treatment of endometriosis","volume":"107","author":"Bedaiwy","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.biopha.2017.03.092","article-title":"A\u00a0peek into the drug development scenario of endometriosis \u2013 a systematic review","volume":"90","author":"Goenka","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GRF.0000000000000292","article-title":"Medical management of endometriosis","volume":"60","author":"Rafique","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/deq302","article-title":"\u201dWaiting for Godot\u201d: a commonsense approach to the medical treatment of endometriosis","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/AOG.0b013e318291f299","article-title":"Lack of transparency of clinical trials on endometriosis","volume":"121","author":"Guo","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.fertnstert.2013.08.050","article-title":"An overview of the current status of clinical trials on endometriosis: issues and concerns","volume":"101","author":"Guo","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jama.2017.10981","article-title":"Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux","volume":"318","author":"Maret-Ouda","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2017.11461","article-title":"The durability of antireflux surgery","volume":"318","author":"Spechler","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bpobgyn.2018.01.015_bib14","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults","author":"Garg","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.fertnstert.2017.09.005","article-title":"Clinical diagnosis of endometriosis and optimal medical therapy","volume":"108","author":"Taylor","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.fertnstert.2017.07.1165","article-title":"Ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial","volume":"108","author":"Harada","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(01)02951-X","article-title":"Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis","volume":"77","author":"Vercellini","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.fertnstert.2005.03.083","article-title":"Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate","volume":"84","author":"Vercellini","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib22","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.fertnstert.2009.01.071","article-title":"Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis","volume":"93","author":"Vercellini","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000337713","article-title":"Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial","volume":"74","author":"Cheewadhanaraks","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1600-0412.2012.01366.x","article-title":"Continuous low-dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography","volume":"91","author":"Ferrari","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jog.12030","article-title":"Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients","volume":"39","author":"Morelli","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/aogs.12326","article-title":"Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study","volume":"93","author":"Leone Roberti Maggiore","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2014.05.016","article-title":"Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura","volume":"179","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0015-0282(16)48430-X","article-title":"American Fertility Society, Revised American Fertility Society classification of endometriosis: 1985.","volume":"43","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2017.01.003","article-title":"Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills","volume":"107","author":"Casper","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmq042","article-title":"Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis","volume":"17","author":"Vercellini","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib31","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/der156","article-title":"Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis","volume":"26","author":"Chapron","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.fertnstert.2010.08.057","article-title":"Endometriosis and estroprogestins: the chicken or the egg causality dilemma","volume":"95","author":"Somigliana","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0029-7844(97)00235-4","article-title":"Menstrual characteristics in women with and without endometriosis","volume":"90","author":"Vercellini","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.fertnstert.2016.07.1075","article-title":"Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis","volume":"106","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.01.013","article-title":"Partial suppression of estradiol: a new strategy in endometriosis management?","volume":"107","author":"Donnez","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.contraception.2016.12.001","article-title":"Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate\/17\u03b2-estradiol and drospirenone\/ethinyl estradiol on bleeding patterns in healthy women","volume":"95","author":"Mansour","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib39","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib40","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"8","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib41","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib42","series-title":"Patient decision aid. Hormone treatment for endometriosis symptoms \u2013 what are my options?","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib43","series-title":"Putting NICE guidance into practice. Hormone therapy for endometriosis symptoms: patient decision aid user guide for healthcare professionals","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib44","series-title":"Endometriosis: diagnosis and management. NICE guideline NG73","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2015.08.074","article-title":"Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis","volume":"214","author":"Muzii","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/humrep\/dew108","article-title":"Personality in women with endometriosis: temperament and character dimensions and pelvic pain","volume":"31","author":"Facchin","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib47","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/humrep\/dex249","article-title":"Mental health in women with endometriosis: searching for predictors of psychological distress","volume":"32","author":"Facchin","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib48","article-title":"\u201cFree butterflies will come out of these deep wounds\u201d: a grounded theory of how endometriosis affects women's psychological health","author":"Facchin","year":"2017","journal-title":"J\u00a0Health Psychol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(03)00608-3","article-title":"Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib51","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1447-0756.2009.01076.x","article-title":"Long-term use of dienogest for the treatment of endometriosis","volume":"35","author":"Momoeda","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/humrep\/dep469","article-title":"Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial","volume":"25","author":"Strowitzki","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00404-016-4184-9","article-title":"Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis","volume":"294","author":"Lee","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/AOG.0b013e3181e8b073","article-title":"Management of endometriosis. ACOG practice bulletin no. 114","volume":"116","author":"American College of Obstetricians and Gynecologists","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib55","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)34589-3","article-title":"Society of obstetricians and gynaecologists of Canada. Endometriosis: diagnosis and management","volume":"32","author":"Leyland","year":"2010","journal-title":"J\u00a0Obstet Gynecol Can"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2014.02.012","article-title":"Treatment of pelvic pain associated with endometriosis: a committee opinion","volume":"101","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib58","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1080\/14656566.2017.1381086","article-title":"Oral and depot progestin therapy for endometriosis: towards a personalized medicine","volume":"18","author":"Buggio","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2018.01.015_bib59","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.bpobgyn.2018.01.015_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate. Pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2013.08.001","article-title":"Potency of progestogens used in hormonal therapy: toward understanding differential actions","volume":"142","author":"Hapgood","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib65","series-title":"Progestogens in obstetrics and gynecology","article-title":"Pharmacology of progestogens","author":"Schindler","year":"2015"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib68","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1933719114549848","article-title":"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density","volume":"21","author":"Carr","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib69","first-page":"24","article-title":"Effect of norethindrone acetate in the treatment of symptomatic endometriosis","volume":"43","author":"Muneyyirci-Delale","year":"1998","journal-title":"Int J Fertil Women's Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib70","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/humrep\/dep302","article-title":"Letrozole combined with norethisterone acetate compared with Norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis","volume":"24","author":"Ferrero","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib71","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/humrep\/dep361","article-title":"Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study","volume":"25","author":"Ferrero","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2010.02.023","article-title":"Letrozole and norethisterone acetate in colorectal endometriosis","volume":"150","author":"Ferrero","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib73","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/humrep\/des313","article-title":"Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction","volume":"27","author":"Vercellini","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/humrep\/det041","article-title":"Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life","volume":"28","author":"Vercellini","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib75","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.fertnstert.2015.11.016","article-title":"Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study","volume":"105","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejogrb.2017.03.033","article-title":"Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis","volume":"213","author":"Morotti","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib77","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","article-title":"Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis related pain: a randomized controlled trial","volume":"119","author":"Tanmahasamut","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib79","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib80","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","article-title":"Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin releasing hormone analogue","volume":"95","author":"Bayoglu Tekin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib81","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1471-0528.2008.02055.x","article-title":"\u2018\u2018Blood on the tracks\u2019\u2019 from corpora lutea to endometriomas","volume":"116","author":"Vercellini","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib82","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/humupd\/dmp007","article-title":"Recurrence of endometriosis and its control","volume":"15","author":"Guo","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib83","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2015.08.026","article-title":"Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis","volume":"104","author":"Koga","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib84","doi-asserted-by":"crossref","first-page":"582.e1","DOI":"10.1016\/j.ajog.2017.02.008","article-title":"Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study","volume":"216","author":"Chen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejps.2014.08.011","article-title":"Evaluation of biodegradable microspheres containing nomegestrol acetate in a rat model of endometriosis","volume":"65","author":"Zhang","year":"2014","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib86","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00404-015-3681-6","article-title":"Dienogest in the treatment of endometriosis: systematic review","volume":"292","author":"Andres Mde","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib87","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(01)03270-8","article-title":"Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study","volume":"77","author":"Cosson","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib88","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis: a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejogrb.2010.04.002","article-title":"Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study","volume":"151","author":"Strowitzki","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.fertnstert.2015.08.031","article-title":"Treatment of pain associated with deep endometriosis: alternatives and evidence","volume":"104","author":"Ferrero","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib91","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.fertnstert.2017.08.038","article-title":"Role of medical therapy in the management of deep rectovaginal endometriosis","volume":"108","author":"Vercellini","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib92","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(99)00291-5","article-title":"A\u00a0levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study","volume":"72","author":"Vercellini","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humrep\/deh004","article-title":"The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease","volume":"19","author":"Lockhat","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2008.07.017","article-title":"Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis\u2014a pilot study","volume":"79","author":"Walch","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib95","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2014.10.036","article-title":"Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment","volume":"183","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib96","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.fertnstert.2011.01.027","article-title":"Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain","volume":"95","author":"Guzick","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib98","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.fertnstert.2007.05.052","article-title":"Maintenance therapy involving a tapering dose of danazol or mid\/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain","volume":"89","author":"Kitawaki","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib99","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejogrb.2011.03.012","article-title":"Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain","volume":"157","author":"Kitawaki","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2016.05.032","article-title":"Hormonal therapy for endometriosis: from molecular research to bedside","volume":"209","author":"Tosti","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib103","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9378(98)70316-3","article-title":"Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)","volume":"178","author":"Kettel","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib104","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.fertnstert.2004.07.825","article-title":"Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil","volume":"82","author":"Chwalisz","year":"2004","journal-title":"Fertil Steril"},{"issue":"32","key":"10.1016\/j.bpobgyn.2018.01.015_bib105","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"1","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib106","unstructured":"reportAustralian government. Department of health. Therapeutic goods administrations. Australian public assessment report for ulipristal acetate. https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-ulipristal-acetate-161019.pdf [Accessed 28 February 2018]."},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib107","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib110","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/humrep\/dep259","article-title":"Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis","volume":"24","author":"Seracchioli","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib111","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/humrep\/deg432","article-title":"Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles","volume":"18","author":"Somigliana","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib112","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/jc.2012-1558","article-title":"The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis","volume":"97","author":"Raffi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib113","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/00016340903214973","article-title":"The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review","volume":"88","author":"Vercellini","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.11.010","article-title":"Postoperative oral contraceptive exposure and risk of endometrioma recurrence","volume":"198","author":"Vercellini","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0412.2012.01470.x","article-title":"Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis","volume":"92","author":"Vercellini","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00404-015-3641-1","article-title":"Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review","volume":"292","author":"Zorbas","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib117","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/humrep\/17.7.1895","article-title":"Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis","volume":"17","author":"Anaf","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib118","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.fertnstert.2011.11.011","article-title":"Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations","volume":"97","author":"McKinnon","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2016.07.497","article-title":"Mechanisms of pain in endometriosis","volume":"209","author":"Morotti","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib120","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/humrep\/det298","article-title":"Is adolescent endometriosis a progressive disease that needs to be diagnosed and treated?","volume":"28","author":"Evers","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib121","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dev157","article-title":"Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal","volume":"30","author":"Vercellini","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib122","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(02)03099-6","article-title":"Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis","volume":"77","author":"Meresman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2012.08.023","article-title":"Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in\u00a0vitro","volume":"166","author":"Minami","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib124","first-page":"827","article-title":"Laparoscopy in the diagnosis of chronic pelvic pain in adolescent women","volume":"34","author":"Vercellini","year":"1989","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib125","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib126","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000001768","article-title":"Practice bulletin No. 174: evaluation and management of adnexal masses","volume":"128","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletin-Gynecology","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib127","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jum.14197","article-title":"First international consensus report on adnexal masses: management recommendations","volume":"36","author":"Glanc","year":"2017","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib128","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.fertnstert.2008.12.114","article-title":"Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis","volume":"93","author":"No\u00ebl","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib129","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib130","first-page":"33","article-title":"Deep infiltrating endometriosis treatment with dienogest: a pilot study","volume":"7","author":"Yela","year":"2015","journal-title":"J\u00a0Endometr Pelvic Pain Disord"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejogrb.2017.02.015","article-title":"Dienogest and deep infiltrating endometriosis: the remission of symptoms is not related to endometriosis nodule remission","volume":"211","author":"Leonardo-Pinto","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2018.01.015_bib132","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/humrep\/dew145","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial","volume":"31","author":"Schultze-Mosgau","year":"2016","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2018.01.015_bib133","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcph.846","article-title":"Model-based dose selection for intravaginal ring formulations releasing anastrozole and levonorgestrel intended for the treatment of endometriosis symptoms","volume":"57","author":"Reinecke","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-017-4448-z","article-title":"\u201cPer vaginam\u201d topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review","author":"Buggio","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/humupd\/dmt027","article-title":"The social and psychological impact of endometriosis on women's lives: a critical narrative review","volume":"19","author":"Culley","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib136","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1177\/1933719117707054","article-title":"What is known and unknown about the association between endometriosis and sexual functioning: a systematic review of the literature","volume":"24","author":"Barbara","year":"2017","journal-title":"Reprod sci"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib137","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/aogs.13031","article-title":"When love hurts. A systematic review on the effects of surgical and pharmacological treatments for endometriosis on female sexual functioning","volume":"96","author":"Barbara","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.bpobgyn.2018.01.015_bib138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/IJWH.S119724","article-title":"Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care","volume":"2","author":"Buggio","year":"2017","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib139","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-017-4117-8","article-title":"International minimally disruptive medicine Workgroup. Assessing the burden of treatment","author":"Spencer-Bonilla","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib140","article-title":"Management of endometriosis: toward value-based, cost-effective, affordable care","author":"Vercellini","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib141","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamainternmed.2013.535","article-title":"Swimming upstream: doing less in health care is hard: comment on \u201cNo Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease\u201d and \u201cCervical cancer screening intervals, 2006 to 2009\u201d","volume":"173","author":"LeFevre","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for health care decision making\u2013an introduction: report 1 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib143","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making\u2013emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib144","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jval.2016.02.020","article-title":"On the estimation of the cost-effectiveness threshold: why, what, how?","volume":"19","author":"Vallejo-Torres","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib145","series-title":"Principles of biomedical ethics","author":"Beauchamp","year":"2013"},{"key":"10.1016\/j.bpobgyn.2018.01.015_bib146","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2017.05.009","article-title":"From evidence-based to hope-based medicine? Ethical aspects on conditional market authorization of and early access to new cancer drugs","volume":"45","author":"Sandman","year":"2017","journal-title":"Semin Cancer Biol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693418300336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:09:24Z","timestamp":1761498564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693418300336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":146,"alternative-id":["S1521693418300336"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.01.015","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical treatment of endometriosis-related pain","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}